홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
NPCE
#2909
Neuropace, Inc. Common Stock
15.510
0
USD
+1.04%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+1.04%
월간 변동
+8.46%
6달 변화
+46.60%
년간 변동율
+46.60%
이전 종가
15.350
0
Open
15.495
0
Bid
Ask
Low
15.466
0
High
15.510
0
양
32
마켓
주식
헬스케어
NPCE
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
32.56 M
32.8 M
33.08 M
33.31 M
33.67 M
—
Valuation ratios
Enterprise value
410.44 M
435.86 M
404.29 M
381.5 M
557.01 M
1.78 B
Price to earnings ratio
-12.03
-14.99
-13.59
-13.93
-23.39
-65.9
Price to sales ratio
4.08
4.33
3.86
3.44
5.05
16.7
Price to cash flow ratio
-18.16
-20.62
-21.24
-19.66
-45.91
-107.42
Price to book ratio
40.67
7.14
5.65
4.69
26.55
44.03
EBITDA 비율에 대한 기업 가치
-19.98
-23.82
-21.44
-22.14
-35.87
-103.27
Profitability ratios
Return on assets %
-0.06
-0.06
-0.08
-0.03
-0.03
-0.2
Return on equity %
-0.66
-0.27
-0.45
-0.19
-0.14
-1.05
Return on invested capital %
—
-67.6
-88.98
-34.72
-23.86
-215.16
Gross margin %
75.41
76.99
77.09
77.39
77.4
308.87
Operating margin %
-17.02
-22.85
-29.01
-9.51
-6.65
-68.02
EBITDA margin %
-16.97
-22.42
-28.35
-8.88
-6.45
-66.1
Net margin %
-24.46
-29.25
-36.78
-12.78
-10.26
-89.08
Liquidity ratios
Quick ratio
4.48
5.7
4.51
3.94
4.33
18.49
Current ratio
5.37
6.63
5.47
4.86
5.28
22.24
Inventory turnover
0.41
0.38
0.36
0.36
0.34
1.45
Asset turnover
0.22
0.22
0.22
0.26
0.25
0.94
Solvency ratios
Debt to assets ratio
0.63
0.54
0.55
0.55
0.56
2.2
Debt to equity ratio
7.43
2.46
3.02
3.17
3.09
11.75
Long term debt to total assets ratio
0.63
0.54
0.55
0.55
0.56
2.2
Long term debt to total equity ratio
7.43
2.46
3.02
3.17
3.09
11.75
Per share metrics
Operating cash flow per share
-0.16
-0.24
-0.06
-0.06
0.02
-0.34
EBIT per share
-0.13
-0.16
-0.21
-0.08
-0.05
-0.5
EBITDA per share
-0.13
-0.16
-0.2
-0.07
-0.05
-0.49
Total debt per share
2.04
1.9
1.78
1.77
1.8
7.26
Cash per share
1.81
2.11
1.89
1.81
1.87
7.67
Net current asset value per share
2.79
3.1
2.85
2.88
2.87
11.7
Tangible book value per share
0.28
0.77
0.59
0.56
0.58
2.5
Working capital per share
2.27
2.63
2.33
2.29
2.33
9.58
Book value per share
0.28
0.77
0.59
0.56
0.58
2.5
뉴스
Key Catalysts That Will Likely Drive Prospects for NPCE Stock in 2026
NPCE RNS System Explained: Growth Drivers and Setup for 2026
NeuroPace's Seizure ID and New Indication Could Expand RNS Demand
뉴로페이스(NPCE) 최고 의료 책임자, 39만 9천 달러 상당의 주식 매도
Neuropace (NPCE) chief medical officer sells $399k in stock
NeuroPace, Inc. (NPCE) Q4 2025 Earnings Call Transcript
NeuroPace, Inc. (NPCE) Reports Q4 Loss, Beats Revenue Estimates
NeuroPace, 4분기 매출 24% 급증…주가 15% 상승
NeuroPace beats estimates as Q4 revenue surges 24%, sending shares up 15%
뉴로페이스 Q4 실적, 수익 예상치를 넘어
Neuropace earnings beat by $0.10, revenue topped estimates
LivaNova (LIVN) Tops Q4 Earnings and Revenue Estimates